(Q34196618)

31 July 2017

1 reference

title

Prophylaxis against herpesvirus infections in transplant recipients (English)

1 reference

31 July 2017

P Ljungman

1

1 reference

31 July 2017

publication date

1 January 2001

1 reference

31 July 2017

1 reference

31 July 2017

volume

61

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

187-196

1 reference

Oral Acyclovir for Prevention of Herpes Simplex Virus Reactivation After Marrow Transplantation

31 July 2017

cites work

1 reference

12 December 2020

Acyclovir prophylaxis of herpes-simplex-virus infections

1 reference

12 December 2020

Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.

1 reference

12 December 2020

Sequential intravenous and twice-daily oral acyclovir for extended prophylaxis of herpes simplex virus infection in marrow transplant patients

1 reference

12 December 2020

Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation

1 reference

12 December 2020

Prevention of herpes simplex virus infection by oral acyclovir after cardiac transplantation

1 reference

12 December 2020

Preventing acute rejection, Epstein-Barr virus infection, and posttransplant lymphoproliferative disorders after kidney transplantation: use of aciclovir and mycophenolate mofetil in a steroid-free immunosuppressive protocol

1 reference

12 December 2020

A prospective randomized study of acyclovir versus ganciclovir plus human immune globulin prophylaxis of cytomegalovirus infection after solid organ transplantation

1 reference

12 December 2020

Foscarnet prophylaxis in marrow transplant recipients

1 reference

12 December 2020

(S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine (cidofovir): results of a phase I/II study of a novel antiviral nucleotide analogue

1 reference

12 December 2020

A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group

1 reference

12 December 2020

CMV prophylaxis with foscarnet in allogeneic bone marrow transplant recipients at high risk of developing CMV infections

1 reference

12 December 2020

Prophylactic oral acyclovir after renal transplantation

1 reference

12 December 2020

A double-blind placebo-controlled trial of low-dose ganciclovir to prevent cytomegalovirus disease after heart transplantation

1 reference

12 December 2020

Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial

1 reference

12 December 2020

A prospective randomized trial comparing sequential ganciclovir-high dose acyclovir to high dose acyclovir for prevention of cytomegalovirus disease in adult liver transplant recipients

1 reference

12 December 2020

Prophylaxis: a strategy to minimise antiviral resistance

1 reference

12 December 2020

Reduced incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy

1 reference

12 December 2020

Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study Group

1 reference

12 December 2020

A comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation.

1 reference

12 December 2020

Randomised comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipients

1 reference

12 December 2020

European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients. Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

1 reference

12 December 2020

Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trial

1 reference

12 December 2020

Randomized, controlled study of the safety and efficacy of intravenous cidofovir for the treatment of relapsing cytomegalovirus retinitis in patients with AIDS.

1 reference

12 December 2020

Long-term acyclovir prophylaxis in bone marrow transplant recipients and lymphocyte proliferation responses to herpes virus antigens in vitro

1 reference

12 December 2020

Two grams daily of oral acyclovir reduces the incidence of cytomegalovirus disease in CMV-seropositive liver transplant recipients

1 reference

12 December 2020

Incidence, distribution, and outcome of episodes of infection in 100 orthotopic liver transplantations

1 reference

12 December 2020

CMV prophylaxis in high-risk renal transplant patients (D+/R-) by acyclovir with or without hyperimmune (CMV) immunoglobulins: a prospective study

1 reference

12 December 2020

High-dose acyclovir compared with short-course preemptive ganciclovir therapy to prevent cytomegalovirus disease in liver transplant recipients. A randomized trial

1 reference

12 December 2020

Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group [corrected].

1 reference

12 December 2020

Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant

1 reference

12 December 2020

A Controlled Trial of Ganciclovir to Prevent Cytomegalovirus Disease after Heart Transplantation

1 reference

12 December 2020

Herpes simplex virus resistant to acyclovir. A study in a tertiary care center

1 reference

12 December 2020

Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis

1 reference

12 December 2020

Long-term survival in allogeneic bone marrow transplant recipients following acyclovir prophylaxis for CMV infection. The European Acyclovir for CMV Prophylaxis Study Group

1 reference

12 December 2020

Prevention of herpesvirus infections in renal allograft recipients by low-dose oral acyclovir

1 reference

12 December 2020

Neutropenia in allogeneic marrow transplant recipients receiving ganciclovir for prevention of cytomegalovirus disease: risk factors and outcome

1 reference

12 December 2020

Effect of acyclovir on infectious mononucleosis: a double-blind, placebo-controlled study

1 reference

12 December 2020

Recurrent Infection with Herpes Simplex Virus after Marrow Transplantation: Role of the Specific Immune Response and Acyclovir Treatment

1 reference

12 December 2020

Antiviral susceptibilities and analysis of UL97 and DNA polymerase sequences of clinical cytomegalovirus isolates from immunocompromised patients

1 reference

12 December 2020

The prophylactic role of intravenous and long-term oral acyclovir after allogeneic bone marrow transplantation

1 reference

12 December 2020

Clinical strategies for the management of cytomegalovirus infection and disease in allogeneic bone marrow transplant

1 reference

12 December 2020

Randomized trial of daily versus three-times-weekly prophylactic ganciclovir after lung and heart-lung transplantation

1 reference

12 December 2020

Forscarnet vs ganciclovir for cytomegalovirus (CMV) antigenemia after allogeneic hemopoietic stem cell transplantation (HSCT): a randomised study

1 reference

12 December 2020

Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation

1 reference

12 December 2020

Phosphorylation of aciclovir, ganciclovir, penciclovir and S2242 by the cytomegalovirus UL97 protein: a quantitative analysis using recombinant vaccinia viruses

1 reference

12 December 2020

Impact of high-dose oral acyclovir prophylaxis on cytomegalovirus (CMV) disease in CMV high-risk renal transplant recipients

1 reference

12 December 2020

A study of the pharmacokinetics, antiviral activity, and tolerability of oral ganciclovir for CMV prophylaxis in marrow transplantation

1 reference

12 December 2020

Prevention of herpes simplex virus (HSV) infection in recipients of HLA-matched T-lymphocyte-depleted bone marrow allografts

1 reference

12 December 2020

Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation

1 reference

12 December 2020

Acyclovir treatment in primary Epstein-Barr virus infection. A double-blind placebo-controlled study.

1 reference

12 December 2020

Foscarnet therapy for acyclovir-resistant mucocutaneous herpes simplex virus infection in 26 AIDS patients: preliminary data

1 reference

12 December 2020

Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: the HPMPC peripheral cytomegalovirus retinitis trial. A randomized, controlled trial. Studies of Ocular complications of AIDS Research Group in Collaboration with the AIDS Cli

1 reference

12 December 2020

Prophylaxis of herpes infections after bone-marrow transplantation by oral acyclovir

1 reference

12 December 2020

Frequency and significance of acyclovir-resistant herpes simplex virus isolated from marrow transplant patients receiving multiple courses of treatment with acyclovir

1 reference

12 December 2020

Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study

1 reference

12 December 2020

A Randomized, Placebo-Controlled Trial of Oral Acyclovir for the Prevention of Cytomegalovirus Disease in Recipients of Renal Allografts

1 reference

12 December 2020

Comparison of intravenous ganciclovir followed by oral acyclovir with intravenous ganciclovir alone for prevention of cytomegalovirus and Epstein-Barr virus disease after liver transplantation in children

1 reference

12 December 2020

Phase I-II trial of foscarnet for prevention of cytomegalovirus infection in autologous and allogeneic marrow transplant recipients

1 reference

12 December 2020

Acyclovir treatment in infectious mononucleosis: a clinical and virological study

1 reference

12 December 2020

Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients. The Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

1 reference

12 December 2020

A randomized prospective controlled trial of oral acyclovir versus oral ganciclovir for cytomegalovirus prophylaxis in high-risk kidney transplant recipients

1 reference

12 December 2020

10.2165/00003495-200161020-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

1001146418

0 references

1 reference